Morris Arleneinsider trades
In SEC Form 4 filings, Morris Arlene is listed as Director of Cogent Biosciences, Inc. (COGT). In the last 90 days, Morris Arlene sold $1.69M of Cogent Biosciences, Inc. (COGT) on the open market and bought none. All 2 sales were reported under a 10b5-1 trading plan.
Companies and roles
| Company | Role | Transactions | Last filed |
|---|---|---|---|
| COGTCogent Biosciences, Inc. | Director | 6 | Aug 31 |
Cluster buys
No cluster buy in the last 90 days included a purchase by this insider (two or more insiders buying within 14 days).
Form 4 historysince 2026-08-31
| Company | Traded | Filed | Type | Shares | Price | Value | Owned after | 10b5-1 plan | Filing |
|---|---|---|---|---|---|---|---|---|---|
| COGTCogent Biosciences, Inc. | Aug 27 | Aug 31 | M | 41,927 | $5.64 | $236,468 | 41,927 | Yes | Form 4 |
| COGTCogent Biosciences, Inc. | Aug 27 | Aug 31 | M | 3,583 | $2.52 | $9,029 | 45,510 | Yes | Form 4 |
| COGTCogent Biosciences, Inc. | Aug 27 | Aug 31 | S | 42,349 | $37.09 | Sale −$1,570,830 | 3,161 | Yes | Form 4 |
| COGTCogent Biosciences, Inc. | Aug 27 | Aug 31 | S | 3,161 | $37.54 | Sale −$118,663 | not reported | Yes | Form 4 |
| COGTCogent Biosciences, Inc. | Aug 27 | Aug 31 | M · derivative | 41,927 | $5.64 | $236,468 | 2,773 | Yes | Form 4 |
| COGTCogent Biosciences, Inc. | Aug 27 | Aug 31 | M · derivative | 3,583 | $2.52 | $9,029 | not reported | Yes | Form 4 |
Published from this insider's public Form 4 filings on SEC EDGAR; the name is shown as filed. Named in a filing and want this page removed? See the privacy policy.